Status of secondary prevention in patients undergoing coronary revascularization

Am J Cardiol. 2001 May 15;87(10):1203-6: A7. doi: 10.1016/s0002-9149(01)01496-5.
No abstract available

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adrenergic beta-Antagonists / therapeutic use
  • Angioplasty, Balloon, Coronary*
  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use
  • Aspirin / therapeutic use
  • Coronary Artery Bypass*
  • Coronary Disease / blood
  • Coronary Disease / drug therapy
  • Coronary Disease / prevention & control
  • Coronary Disease / therapy*
  • Female
  • Guideline Adherence
  • Humans
  • Hypolipidemic Agents / therapeutic use*
  • Lipids / blood
  • Male
  • Middle Aged
  • Practice Guidelines as Topic
  • Recurrence
  • Risk Factors

Substances

  • Adrenergic beta-Antagonists
  • Angiotensin-Converting Enzyme Inhibitors
  • Hypolipidemic Agents
  • Lipids
  • Aspirin